Skip to main content
Clinical Trials/NCT03760432
NCT03760432RecruitingNot Applicable

Clinical Trial of Laser Custom Corneal Collagen Cross-Linking in Keratoconus

Oregon Health and Science University1 site in 1 country100 target enrollmentStarted: June 20, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
100
Locations
1
Primary Endpoint
Improvement in best spectacle-corrected visual acuity after laser custom CXL

Study Overview

Brief Summary

Optical Coherence Tomography (OCT) devices are non-contact instruments that can measure the depth of scars, other causes of cloudiness of the cornea, and degree of corneal thinning in patients with keratoconus. Laser Custom Corneal Collagen Cross-linking (CXL) significantly decreases corneal aberrations and improves vision. This study will use OCT-guided setting for the lasers used in the corneal smoothing portion of the laser custom CXL procedure to assess the affect on visual outcomes.

Detailed Description

In the U.S., CXL and topography-guided laser ablation were approved independently, but not together. Another variation in technique involves the use of mitomycin-C (MMC), which is effective in reducing corneal haze after the laser surface ablation. Use of MMC during the laser custom CXL was associated with better outcomes, but in separate trials that could not be directly compared. This study will use OCT measurements to evaluate the magnitudes of direct and indirect laser actions after the procedure.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Diagnosis of keratoconus
  • •Minimum corneal thickness of 410 microns

Exclusion Criteria

  • •Inability to maintain fixation for OCT imaging
  • •Inability to commit to required study visits
  • •Inability to give informed consent
  • •Eyes with concurrent retinal diseases, glaucoma, or other eye conditions that may limit the visual outcome after surgery
  • •Mature cataracts if found to limit visual potential to worse than 20/40

Arms & Interventions

Surgery

Experimental

OCT-guided custom laser CXL

Intervention: Laser Custom Corneal Collagen Cross-Linking (Procedure)

Outcomes

Primary Outcomes

Improvement in best spectacle-corrected visual acuity after laser custom CXL

Time Frame: 6 months after the CXL procedure

The primary goal of the trial is to determine the extent of visual improvement after laser custom CXL compared to preoperative measurements. Vision will be checked at various time points, but the primary time point will be 6-months post-procedure.

Secondary Outcomes

  • Determine CXL demarcation line depth(1 month after the CXL procedure)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

David Huang

Peterson Professor of Ophthalmology & Professor of Biomedical Engineering

Oregon Health and Science University

Study Sites (1)

Loading locations...

Similar Trials